Partner With Us
Bayer actively seeks partnerships with industry and academia Read More

Bayer has a growing biotechnology presence in the San Francisco Bay Area and extending up the west coast of the United States. Our Berkeley biomanufacturing center produces Kogenate® FS*, a key treatment for people living with hemophilia A. In 2007, the company acquired biomanufacturing facilities in Emeryville, Calif., which manufacture Betaseron®, a leading biological product for the treatment of Multiple Sclerosis. This strategic acquisition further strengthened Bayer's growing biotech presence in and commitment to the Bay Area, one of the world's most active biotech corridors.
In addition to the Bay Area sites, a biomanufacturing facility in the Seattle, Washington area produces Leukine®, the company's white blood cell growth factor for Genzyme Corporation.
* BETASERON® (Interferon beta-1b) Prescribing Information.
* Kogenate® FS Antihemophilic Factor (Recombinant) Prescribing Information.
* LEUKINE® (sargramostim) Prescribing Information.